F-star Therapeutics, Inc. Common Stock (FSTX)

FSTX was delisted on the 8th of March, 2023.

• Market cap: $157M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

Employees: 88